Pioneering Treatments

The New York Eye Cancer Center (NYECC) is a pioneer in the diagnosis and treatment of eye cancer. NYECC Director Dr. Paul Finger has driven research into radiation therapy for eye cancers. His expertise has been recognized by both the American Brachytherapy Society (ABS) and the American Association of Physicists in Medicine (AAPM) who have asked him to create consensus guidelines for eye plaque radiation therapy.

Upload: December 1, 2015Dr. Finger helped create the consensus guidelines for eye plaque radiation therapy for the ABS and AAPM.Dr. Finger invented the use of palladium-103 plaque brachytherapy for intraocular melanoma as well as high-dose-rate treatment for melanoma extension behind the eye. No matter where the patients eye melanoma extends, the doctors at the NYECC can treat it.

Dr. Finger first demonstrated how ultrasonic biomicroscopy could be used for the diagnosis of childhood retinoblastoma and other eye cancers. This technique provides clearer, more detailed images of the front of the eye than traditional ultrasound. He’s also pioneered the use of OCT (Optical Coherence Tomography) for radiation retinopathy. The OCT technique that creates 3D images of the retina and is one of the best diagnostic tools in the industry.

OCT creates 3D images that allows Dr. Finger to virtually "peel back" the layers of the retina.
OCT creates 3D images that allows Dr. Finger to virtually “peel back” the layers of the retina.

Once Dr. Finger makes a diagnosis, he employs innovative treatments developed at the NYECC and that have become industry standards. This includes a breakthrough technique to treat “melanoma” the most common cancer within the eye, offering comparatively better vision outcomes than other treatments.

Dr. Finger pioneered the use of slotted eye plaques, making it possible to save the eyes of patients whose choroidal melanoma is wrapped around, touching or near the optic nerve. He also invented a biopsy technique for iris melanoma, using a micro-incision aspiration cutter that offers increased safety and effectiveness.

Dr. Finger invented the slotted eye plaque to cover and treat the posterior portion of a tumor that came within 1.5 mm, touched or surrounded the optic nerve.
Dr. Finger invented slotted eye plaques to cover and treat the posterior portion of tumors that come within 1.5 mm, touch, or surround the optic nerve.

Striving for excellence through innovation, Dr. Finger and the NYECC are able to offer treatments that may not be available anywhere else. Our mission is to achieve the best outcome with the least amount of risk. We deploy the latest techniques and technology available to treat our patients, then seek to improve outcomes even further with each case. Dr. Finger says, “it is careful attention to detail (for each patient) that allows patients at NYECC to do so well.”

Delivering the best outcome is the heart of our philosophy of patient-centered care.

 

Continue to Patient-Centered Care »

Patient Stories

"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
N.N.

Read More

REQUEST AN APPOINTMENT

  • This field is for validation purposes and should be left unchanged.

CONNECT AND SHARE